AMAG launches anemia drug in Europe

Filed under: drug treatment news 2012

… European regulators for Rienso in June 2012 for treatment of iron-deficiency anemia in patients with chronic kidney disease, which is the same indication as the U.S. version, Feraheme, which was approved by the U.S. Food and Drug Administration in …
Read more on Mass High Tech

Sanofi draws fire over cost of MS drug Lemtrada

Filed under: drug treatment news 2012

The injectable drug, chemically known as alemtuzumab, was sold until September 2012 under the name Campath as treatment for leukemia and given more frequently at a higher dosage. "There is concern that with a license for multiple sclerosis, the cost of …
Read more on Reuters

Failed AstraZeneca Drugs Seen Holding Key to Next Viagra

Filed under: drug treatment news 2012

By Allison Connolly – 2012-10-31T20:38:47Z. (Corrects clinical trial sponsor in ninth paragraph.) A failed prostate cancer drug might reverse Alzheimer's. A former lung disease medicine may stop the ravages of muscular dystrophy. An experimental …
Read more on Bloomberg

Europe approves high-price gene therapy

Filed under: drug treatment news 2012

LONDON | Fri Nov 2, 2012 7:59am EDT. LONDON (Reuters) – European officials have approved the Western world's first gene therapy drug from a small Dutch biotech company, in a milestone for the novel medical technology that fixes faulty genes.
Read more on Reuters